AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12088158 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 85
Study 12088158 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study 12088158 — intervention group
Group type: COMPARATOR
Intervention: Healthy Control
Number of subjects: 85
Study 28929862 — intervention group
Group type: EXPERIMENTAL
Intervention: Computed tomography analyzed by experienced consultant radiologists
Number of subjects: 1065
Study 28929862 — intervention group
Group type: COMPARATOR
Intervention: Computed tomography analyzed by inexperienced resident radiologists
Number of subjects: 1065
Study 27212669 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 139
Study 27212669 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 139
Study 24858309 — intervention group
Group type: EXPERIMENTAL
Intervention: Feature-present arrays (R among Ps)
Number of subjects: 0
Study 24858309 — intervention group
Group type: EXPERIMENTAL
Intervention: Feature-absent arrays (P among Rs)
Number of subjects: 0
Study 24858309 — intervention group
Group type: EXPERIMENTAL
Intervention: Homogeneous arrays (either all Rs or all Ps)
Number of subjects: 0
Study 22200516 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 240
Study 22200516 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study 20362978 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy techniques adherence (cognitive methods and negotiating content/structuring sessions)
Number of subjects: 60
Study 20362978 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient facilitation or inhibition of therapist adherence
Number of subjects: 60
Study 20362978 — intervention group
Group type: COMPARATOR
Intervention: Behavioral methods/homework adherence
Number of subjects: 60
Study 20362978 — intervention group
Group type: COMPARATOR
Intervention: Therapeutic alliance
Number of subjects: 60
Study 18448749 — intervention group
Group type: EXPERIMENTAL
Intervention: Trendelenburg position (30 degrees) and a pulmonary recruitment maneuver consisting of five manual inflations of the lung
Number of subjects: 116
Study 18448749 — intervention group
Group type: COMPARATOR
Intervention: Passive deflation of the abdominal cavity through the cannula (Control group)
Number of subjects: 116
Study 15449050 — intervention group
Group type: EXPERIMENTAL
Intervention: ECG-gated 18F-FDG/(99m)Tc-sestamibi DISA SPECT
Number of subjects: 33
Study 15449050 — intervention group
Group type: EXPERIMENTAL
Intervention: (99m)Tc-sestamibi
Number of subjects: 33
Study 15449050 — intervention group
Group type: COMPARATOR
Intervention: 18F-FDG/13N-ammonia PET
Number of subjects: 33
Study 15449050 — intervention group
Group type: COMPARATOR
Intervention: Cine-MRI
Number of subjects: 33
Study 12172954 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular high molecular weight hyaluronan injection after arthrocentesis
Number of subjects: 118
Study 12172954 — intervention group
Group type: COMPARATOR
Intervention: No arthrocentesis before hyaluronan injection
Number of subjects: 118
Study 10439751 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal fentanyl 5, 7.5, 10, 15, 20, or 25 micrograms
Number of subjects: 90
Study 10439751 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal fentanyl
Number of subjects: 90
Study 7873109 — intervention group
Group type: EXPERIMENTAL
Intervention: Dance-based exercise program (12 weeks, twice weekly)
Number of subjects: 19
Study 7873109 — intervention group
Group type: COMPARATOR
Intervention: Control group (10 participants, mean age 49.4 ± 12 years)
Number of subjects: 19
Study 2240504 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine 2.5 micrograms/kg
Number of subjects: 36
Study 2240504 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine 5.0 micrograms/kg
Number of subjects: 36
Study 2240504 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol infusion
Number of subjects: 36
Study 2240504 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged infusions of propofol
Number of subjects: 36
Study 2240504 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative questioning
Number of subjects: 36
Study 359081 — intervention group
Group type: EXPERIMENTAL
Intervention: Mianserin 20 mg three times daily plus placebo lithium tablets
Number of subjects: 41
Study 359081 — intervention group
Group type: COMPARATOR
Intervention: Lithium tablets once daily plus placebo mianserin tablets
Number of subjects: 41
Study 359081 — intervention group
Group type: EXPERIMENTAL
Intervention: Mianserin 20 mg three times daily (increased to 30 mg t.d.s. after one year)
Number of subjects: 41
Study 359081 — intervention group
Group type: COMPARATOR
Intervention: Lithium tablets once daily
Number of subjects: 41
Study 29943177 — intervention group
Group type: EXPERIMENTAL
Intervention: Monarc® (outside-in trans-obturator technique)
Number of subjects: 120
Study 29943177 — intervention group
Group type: COMPARATOR
Intervention: TVT-O® (inside-out trans-obturator technique)
Number of subjects: 120
Study 29943177 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 120
Study 29916428 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic hydration
Number of subjects: 0
Study 29916428 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 25980552 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine (40-60 mg/day)
Number of subjects: 1522
Study 25980552 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1522
Study 23859696 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 1071
Study 23859696 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine Replacement Therapy (NRT)
Number of subjects: 1071
Study 23859696 — intervention group
Group type: EXPERIMENTAL
Intervention: NRT plus bupropion
Number of subjects: 1071
Study 23859696 — intervention group
Group type: COMPARATOR
Intervention: NRT
Number of subjects: 1071
Study 21809362 — intervention group
Group type: EXPERIMENTAL
Intervention: BMS-790052 (1, 10, 30, 60, and 100 mg, once-daily or 30 mg twice-daily)
Number of subjects: 24
Study 21809362 — intervention group
Group type: EXPERIMENTAL
Intervention: BMS-790052
Number of subjects: 24
Study 19734380 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (8 weekly sessions using four bilateral acupuncture points)
Number of subjects: 12
Study 16455695 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mug oral misoprostol solution at hourly intervals
Number of subjects: 741
Study 16455695 — intervention group
Group type: COMPARATOR
Intervention: Vaginal dinoprostone gel at six hourly intervals
Number of subjects: 741
Study 12677735 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-nasal mometasone furoate (MF) 200 mg once daily
Number of subjects: 22
Study 12677735 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 10933100 — intervention group
Group type: EXPERIMENTAL
Intervention: LPS (lipopolysaccharide)
Number of subjects: 10
Study 10933100 — intervention group
Group type: EXPERIMENTAL
Intervention: GLU (beta‐1,3‐D‐glucan)
Number of subjects: 10
Study 10933100 — intervention group
Group type: EXPERIMENTAL
Intervention: LPS
Number of subjects: 10
Study 10933100 — intervention group
Group type: EXPERIMENTAL
Intervention: GLU
Number of subjects: 10
Study 10933100 — intervention group
Group type: COMPARATOR
Intervention: Control group (saline)
Number of subjects: 10
Study 8822346 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training (3 x 8 repetition maximum)
Number of subjects: 56
Study 8822346 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training (3 x 20 repetition maximum)
Number of subjects: 56
Study 1579391 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 micrograms of budesonide
Number of subjects: 43
Study 1579391 — intervention group
Group type: COMPARATOR
Intervention: 200 micrograms of budesonide
Number of subjects: 43
Study 1579391 — intervention group
Group type: COMPARATOR
Intervention: 400 micrograms of budesonide
Number of subjects: 43
Study 1579391 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 3913177 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolysis
Number of subjects: 185
Study 3913177 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 185
Study 31613942 — intervention group
Group type: EXPERIMENTAL
Intervention: Feather-edge preparation (Group 1)
Number of subjects: 50
Study 31613942 — intervention group
Group type: COMPARATOR
Intervention: Chamfer preparation (Group 2)
Number of subjects: 50
Study 30128724 — intervention group
Group type: EXPERIMENTAL
Intervention: Doula-Home-Visiting Services
Number of subjects: 0
Study 26063452 — intervention group
Group type: COMPARATOR
Intervention: Fluoroscopy-guided targeted continuous cervical epidural block (FCCEB)
Number of subjects: 75
Study 26063452 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided continuous interscalene brachial plexus block (UCISB75)
Number of subjects: 75
Study 26063452 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided continuous interscalene brachial plexus block (UCISB20)
Number of subjects: 75
Study 25509262 — intervention group
Group type: EXPERIMENTAL
Intervention: Xuebijing Injection (50 mL XI in 100 mL normal saline, injected twice daily for 3 days post-THA)
Number of subjects: 80
Study 25509262 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine perioperative therapies only)
Number of subjects: 80
Study 22734945 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention schools (n=4)
Number of subjects: 579
Study 22734945 — intervention group
Group type: COMPARATOR
Intervention: Control schools (n=4)
Number of subjects: 579
Study 20333473 — intervention group
Group type: EXPERIMENTAL
Intervention: ECMO therapy
Number of subjects: 0
Study 20333473 — intervention group
Group type: COMPARATOR
Intervention: Long-term, large-scale observational study
Number of subjects: 0
Study 17697016 — intervention group
Group type: EXPERIMENTAL
Intervention: peginterferon (peg-IFN) alpha 2b plus ribavirin
Number of subjects: 416
Study 17697016 — intervention group
Group type: COMPARATOR
Intervention: interferon alpha-2b plus ribavirin
Number of subjects: 416
Study 17697016 — intervention group
Group type: EXPERIMENTAL
Intervention: zidovudine
Number of subjects: 416
Study 17697016 — intervention group
Group type: EXPERIMENTAL
Intervention: peg-IFN
Number of subjects: 416
Study 17697016 — intervention group
Group type: EXPERIMENTAL
Intervention: higher baseline haemoglobin levels
Number of subjects: 416
Study 17697016 — intervention group
Group type: EXPERIMENTAL
Intervention: protease inhibitor-based antiretroviral therapy
Number of subjects: 416
Study 16259547 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone at flexible doses of 0.5 to 1.5 mg/day
Number of subjects: 40
Study 16259547 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 12080281 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyridoxine (100 mg)
Number of subjects: 12
Study 12080281 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 10378497 — intervention group
Group type: COMPARATOR
Intervention: Moderate-Intensity Exercise Group (MIG)
Number of subjects: 25
Study 10378497 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Exercise Group (HIG)
Number of subjects: 25
Study 8679761 — intervention group
Group type: EXPERIMENTAL
Intervention: Fundoplication with total fundal mobilisation (n = 10)
Number of subjects: 20
Study 8679761 — intervention group
Group type: COMPARATOR
Intervention: Conventional Nissen‐Rossetti procedure (n = 10)
Number of subjects: 20
Study 1829401 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 10
Study 1829401 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 6365468 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg fentiazac twice daily for 6 weeks
Number of subjects: 44
Study 6365468 — intervention group
Group type: COMPARATOR
Intervention: 50 mg indomethacin twice daily for 6 weeks
Number of subjects: 44
Study 6365468 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg fentiazac twice daily for 2 weeks
Number of subjects: 44
Study 6365468 — intervention group
Group type: COMPARATOR
Intervention: 200 mg phenylbutazone twice daily for 2 weeks
Number of subjects: 44
Study 30006778 — intervention group
Group type: EXPERIMENTAL
Intervention: Low supplementation (LOHI; 0.2% of BW/heifer/day) for first 90 days, high supplementation (0.6% of BW/heifer/day) for next 90 days
Number of subjects: 48
Study 30006778 — intervention group
Group type: EXPERIMENTAL
Intervention: Average supplementation (AVER; 0.4% of BW/heifer/day for 180 days)
Number of subjects: 48
Study 30006778 — intervention group
Group type: EXPERIMENTAL
Intervention: High supplementation (HILO; 0.6% of BW/heifer/day for first 90 days, low supplementation (0.2% of BW/heifer/day) for next 90 days
Number of subjects: 48
Study 30006778 — intervention group
Group type: COMPARATOR
Intervention: Only mineral mix (MM) ad libitum during 180 days
Number of subjects: 48
Study 28835229 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg once daily
Number of subjects: 0
Study 28835229 — intervention group
Group type: COMPARATOR
Intervention: Standard care (placebo)
Number of subjects: 0
Study 26717405 — intervention group
Group type: EXPERIMENTAL
Intervention: OraQuick Rapid HIV‐1/2 antibody test
Number of subjects: 3678
Study 26717405 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir
Number of subjects: 3678
Study 26717405 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3678
Study 26717405 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV CRF01_AE
Number of subjects: 3678
Study 23627281 — intervention group
Group type: EXPERIMENTAL
Intervention: Working memory dual-task during acquisition
Number of subjects: 0
Study 23627281 — intervention group
Group type: EXPERIMENTAL
Intervention: Working memory dual-task at test
Number of subjects: 0
Study 23627281 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-task conditions in Experiment 2
Number of subjects: 0
Study 21383650 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine (CsA) treatment
Number of subjects: 171
Study 18488812 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg delayed-released tablet (test formulation) without food
Number of subjects: 0
Study 18488812 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg delayed-released tablet (test formulation) with food
Number of subjects: 0
Study 18488812 — intervention group
Group type: COMPARATOR
Intervention: Reference pantoprazole 40 mg delayed-released tablet
Number of subjects: 0
Study 16585381 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle energy technique
Number of subjects: 32
Study 16585381 — intervention group
Group type: COMPARATOR
Intervention: Sham manipulative treatment
Number of subjects: 32
Study 15603634 — intervention group
Group type: EXPERIMENTAL
Intervention: Videoconferencing (intervention group)
Number of subjects: 100
Study 15603634 — intervention group
Group type: COMPARATOR
Intervention: Audioconferencing (control group)
Number of subjects: 100
Study 10699344 — intervention group
Group type: EXPERIMENTAL
Intervention: Biojector(R) jet-injection system
Number of subjects: 1440
Study 10699344 — intervention group
Group type: COMPARATOR
Intervention: Needle injection method
Number of subjects: 1440
Study 9491679 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemagglutination test using sensitized sheep red blood cells
Number of subjects: 530
Study 9491679 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemagglutination inhibition test for detection of LPS antigen of S. typhi
Number of subjects: 530
Study 9491679 — intervention group
Group type: COMPARATOR
Intervention: Haemagglutination test
Number of subjects: 530
Study 9491679 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemagglutination inhibition test
Number of subjects: 530
Study 8466095 — intervention group
Group type: EXPERIMENTAL
Intervention: Bricanyl Turbuhaler (BTH)
Number of subjects: 159
Study 8466095 — intervention group
Group type: COMPARATOR
Intervention: Ventolin metered-dose inhaler (VMDI)
Number of subjects: 159
Study 3780329 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam (0.5 mg bid)
Number of subjects: 24
Study 3780329 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 3281449 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferric polymaltose at a dose of 100 mg elemental iron twice daily for 56 days (group 1a)
Number of subjects: 46
Study 3281449 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablet administered on the same schedule (group 1b)
Number of subjects: 46
Study 3281449 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferric polymaltose at a dose of 100 mg elemental iron twice daily for 56 days (group 2a)
Number of subjects: 46
Study 3281449 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablet administered on the same schedule (group 2b)
Number of subjects: 46
Study 29454711 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumescent technique
Number of subjects: 160
Study 29454711 — intervention group
Group type: COMPARATOR
Intervention: Tourniquet
Number of subjects: 160
Study 25782762 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy for antepartum depression (IPT-P)
Number of subjects: 142
Study 25782762 — intervention group
Group type: COMPARATOR
Intervention: Parenting education program (PEP)
Number of subjects: 142
Study 23582165 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic supplementation
Number of subjects: 45
Study 23582165 — intervention group
Group type: COMPARATOR
Intervention: Minocycline
Number of subjects: 45
Study 23582165 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic and minocycline
Number of subjects: 45
Study 21114777 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemoradiation with 5‐fluorouracil/cisplatin (FP) followed by radiation (4500 cGY) and additional cycles of FP (arm A)
Number of subjects: 61
Study 21114777 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy with 5‐fluorouracil/cisplatin (FP) (arm B)
Number of subjects: 61
Study 18208835 — intervention group
Group type: COMPARATOR
Intervention: Diuretics alone
Number of subjects: 150
Study 18208835 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretics plus irbesartan
Number of subjects: 150
Study 18208835 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretics plus ramipril
Number of subjects: 150
Study 17010798 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine (20 to 40 mg)
Number of subjects: 209
Study 17010798 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine (30 mg/day for 6 months)
Number of subjects: 209
Study 17010798 — intervention group
Group type: COMPARATOR
Intervention: Teprenone
Number of subjects: 209
Study 14685865 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise in the heat at an ambient temperature of 35 degrees C (H)
Number of subjects: 7
Study 14685865 — intervention group
Group type: COMPARATOR
Intervention: Exercise in the cool at 15 degrees C (C)
Number of subjects: 7
Study 11767419 — intervention group
Group type: COMPARATOR
Intervention: Positive control (similar to the supplement in the pilot study)
Number of subjects: 12
Study 11767419 — intervention group
Group type: COMPARATOR
Intervention: Polar olive oil phenols
Number of subjects: 12
Study 11767419 — intervention group
Group type: COMPARATOR
Intervention: Placebo (without phenols)
Number of subjects: 12
Study 11767419 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-polar olive oil phenols
Number of subjects: 12
Study 9043728 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane 1.0 to 1.5% (end-tidal) with nitrous oxide 66% in oxygen; anaesthesia induced with 5 mg.kg-1 thiopentone.
Number of subjects: 24
Study 8330464 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 mg alprazolam daily
Number of subjects: 12
Study 8330464 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg alprazolam daily
Number of subjects: 12
Study 3487646 — intervention group
Group type: EXPERIMENTAL
Intervention: D-penicillamine (DP) 500 mg daily
Number of subjects: 148
Study 3487646 — intervention group
Group type: EXPERIMENTAL
Intervention: D-penicillamine (DP) 125 mg daily
Number of subjects: 148
Study 3487646 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study 30284878 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Repeated Mailings (IRM)
Number of subjects: 1874
Study 30284878 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Repeated Mailings (SRM)
Number of subjects: 1874
Study 30284878 — intervention group
Group type: COMPARATOR
Intervention: Traditional Self‐Help (TSH)
Number of subjects: 1874
Study 27776251 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide BID
Number of subjects: 114
Study 27776251 — intervention group
Group type: COMPARATOR
Intervention: Insulin lispro
Number of subjects: 114
Study 24495519 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic communication skills training (BCST) for nurses
Number of subjects: 89
Study 24495519 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmentative and alternative communication devices and speech language pathologist consultation (AAC + SLP)
Number of subjects: 89
Study 24495519 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 89
Study 22342792 — intervention group
Group type: EXPERIMENTAL
Intervention: Nail pick during surgical scrub
Number of subjects: 60
Study 22342792 — intervention group
Group type: EXPERIMENTAL
Intervention: Brush during surgical scrub
Number of subjects: 60
Study 22342792 — intervention group
Group type: COMPARATOR
Intervention: Surgical scrub alone (control group)
Number of subjects: 60
Study 20590963 — intervention group
Group type: COMPARATOR
Intervention: Coronally advanced flap (CAF) with connective tissue graft (CTG)
Number of subjects: 50
Study 20590963 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronally advanced flap (CAF) with de-epithelialized gingival graft (DGG)
Number of subjects: 50
Study 18325725 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-2 (12 million UI/day for 3 days before operation)
Number of subjects: 20
Study 18325725 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 20
Study 15988076 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin (40-45 mg/kg/24 h) + Sinupret (mucoregulatory remedy)
Number of subjects: 64
Study 15988076 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin (40-45 mg/kg/24 h)
Number of subjects: 64